Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis.
D001487:Basidiomycota; D002614:Chelating Agents; D004492:Edetic Acid; D006801:Humans; D011736:Pyridoxine; D012594:Scleroderma, Localized; D012595:Scleroderma, Systemic; D014364:Tryptophan
D002614:Chelating Agents; D014364:Tryptophan; D004492:Edetic Acid; D011736:Pyridoxine
EDATHAMIL; PYRIDOXINE; SCLERODERMA; TRYPTOPHAN